Decoy Therapeutics (Merged) Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
Decoy Therapeutics (Merged) General Information
Description
Developer of immunotherapy products designed for addressing cancer treatment challenges. The company leverages proprietary technology to develop therapies that target immune system pathways, incorporating innovative approaches to enhance efficacy and minimize side effects, enabling doctors with access to advanced treatment options while improving overall outcomes in oncology care.
Contact Information
(Operating Subsidiary)
Corporate Office
- One Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Corporate Office
- One Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Decoy Therapeutics (Merged) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 13-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC | 14-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 30-Jun-2024 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC | Completed | Pre-Clinical Trials | ||||
| 4. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 3. Debt - General | 01-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 15-Jul-2022 | $250K | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 22-Apr-2021 | $250K | $250K | Completed | Pre-Clinical Trials |
Decoy Therapeutics (Merged) Comparisons
Industry
Financing
Details
Decoy Therapeutics (Merged) Competitors (3)
One of Decoy Therapeutics (Merged)’s 3 competitors is Nexoplex bio, a Formerly VC-backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nexoplex bio | Formerly VC-backed | Emeryville, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Recursion Pharmaceuticals | Formerly VC-backed | Salt Lake City, UT |
Decoy Therapeutics (Merged) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Decoy Therapeutics (Merged) Patents
Decoy Therapeutics (Merged) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260131011-A1 | Anti-viral therapeutic peptides, conjugates, and methods of use thereof | Pending | 30-Apr-2024 | ||
| US-20260077052-A1 | Methods for reducing or preventing sars-cov-2 infection and transmission | Pending | 30-Apr-2024 | ||
| WO-2025231155-A2 | Methods for reducing or preventing sars-cov-2 infection and transmission | Pending | 30-Apr-2024 | ||
| WO-2025231155-A3 | Methods for reducing or preventing sars-cov-2 infection and transmission | Pending | 30-Apr-2024 | ||
| WO-2025231157-A2 | New anti-viral therapeutic peptides, conjugates, and methods of use thereof | Pending | 30-Apr-2024 | C07K14/005 |
Decoy Therapeutics (Merged) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Decoy Therapeutics (Merged) Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BARDA | Government | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Gates Family Foundation | Not-For-Profit Venture Capital | Minority | ||
| Johnson & Johnson | Corporation | Minority | ||
| MIT Startup Exchange | Accelerator/Incubator |
Decoy Therapeutics (Merged) FAQs
-
When was Decoy Therapeutics (Merged) founded?
Decoy Therapeutics (Merged) was founded in 2020.
-
Where is Decoy Therapeutics (Merged) headquartered?
Decoy Therapeutics (Merged) is headquartered in Cambridge, MA.
-
What is the size of Decoy Therapeutics (Merged)?
Decoy Therapeutics (Merged) has 7 total employees.
-
What industry is Decoy Therapeutics (Merged) in?
Decoy Therapeutics (Merged)’s primary industry is Drug Discovery.
-
Is Decoy Therapeutics (Merged) a private or public company?
Decoy Therapeutics (Merged) is a Private company.
-
What is Decoy Therapeutics (Merged)’s current revenue?
The current revenue for Decoy Therapeutics (Merged) is .
-
How much funding has Decoy Therapeutics (Merged) raised over time?
Decoy Therapeutics (Merged) has raised $8.45M.
-
Who are Decoy Therapeutics (Merged)’s investors?
BARDA, Creative Destruction Lab, Gates Family Foundation, Johnson & Johnson, and MIT Startup Exchange are 5 of 9 investors who have invested in Decoy Therapeutics (Merged).
-
Who are Decoy Therapeutics (Merged)’s competitors?
Nexoplex bio, Exscientia, and Recursion Pharmaceuticals are competitors of Decoy Therapeutics (Merged).
-
When was Decoy Therapeutics (Merged) acquired?
Decoy Therapeutics (Merged) was acquired on 13-Jan-2025.
-
Who acquired Decoy Therapeutics (Merged)?
Decoy Therapeutics (Merged) was acquired by Decoy Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
